Contrast-enhanced MRI

Principles of Magnetic Resonance Imaging

MRI operates using a powerful superconducting magnet (field strength typically 1.5 T, 3 T, or 7 T), radiofrequency pulses, and gradient coils. The technique is based on the phenomenon of magnetic resonance: hydrogen nuclei (protons), present in the body's water and lipids, align along the vector of a strong external magnetic field. When a radiofrequency pulse is applied, their magnetization is deflected, and as they return to their baseline state, the nuclei emit a signal that is detected by the scanner.

The main advantages of MRI over CT are the absence of ionizing radiation (it uses electromagnetic radiation in the radiofrequency range) and superior soft tissue detail. However, MRI is more time-consuming, more expensive, has specific contraindications (such as the presence of metal implants), and is accompanied by loud acoustic noise during gradient coil operation.

Contrast-Enhanced MRI in Oncology

In oncology, MRI has become the primary imaging modality for evaluating many types of cancer, such as tumors of the prostate, rectum, cervix, and endometrium.

Functional imaging techniques hold a special place:

• Dynamic Contrast-Enhanced MRI (DCE-MRI): allows the evaluation of tissue perfusion and vascular permeability. Unlike CT, the absence of radiation exposure allows continuous data acquisition across all phases of contrast enhancement.
• Dynamic Susceptibility Contrast MRI (DSC-MRI): is based on the signal loss effect (transient darkening) during contrast passage (T2 and T2^* weighting). It allows the estimation of relative blood volume (rBV), which is useful for grading gliomas and differentiating tumor recurrence from radiation necrosis.

In tumors, angiogenesis forms a chaotic vascular network with high permeability. When a low-molecular-weight contrast agent is administered, it rapidly diffuses into the extravascular extracellular space. Pharmacokinetic analysis, specifically the $K^{trans}$ parameter (volume transfer constant between plasma and tissue), serves as a reliable biomarker of tumor response to therapy, especially anti-angiogenic therapy.

Safety of Contrast Agents

Gadolinium-based contrast agents are used in MRI. Although they are considered safe, there are several important limitations:

• Nephrogenic Systemic Fibrosis (NSF): a rare but dangerous complication occurring in patients with severe renal impairment, caused by the accumulation of free gadolinium.
• Brain Deposition: it has been proven that free gadolinium can accumulate in brain structures (e.g., the dentate nucleus). Currently, there is no evidence that this causes clinical harm.

According to guidelines, preference should be given to macrocyclic agents (gadobutrol, gadoterate meglumine, gadoteridol) because they are more stable and release free gadolinium less frequently than linear chelates. Contrast agents should be used only for strict indications and at the minimum effective dose.

What else to study on this topic

• Mathematical Modeling of Pharmacokinetics in DCE-MRI ($v_e$, $v_p$, $k_{ep}$ parameters)
• Differences Between $T_1$-, $T_2$-Weighted Images and DWI
• Principles of BOLD MRI in Tissue Hypoxia Assessment
• The Role of MRI in Myocardial Viability and Infarction Assessment
• Comparison of Contrast Safety for MRI (Gadolinium) and CT (Iodine)

Other topics in the "Diagnostic Radiology in Oncology" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.